News
The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...
Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.
While you may start with a certain regimen, you may not sick to it. Here are 7 signs that your asthma medication isn't ...
Asthma is a condition with varying levels of care for a variety of reasons; it is critical that people with asthma symptoms ...
The latest UK asthma guidelines1 clearly define the role of Fractional exhaled Nitric Oxide (FeNO) testing in both diagnosing ...
Patients with severe asthma who initiate biologics may reduce their risk for oral corticosteroids (OCS)-related new-onset adverse outcomes.
The programs cost way more than officials had projected at a time when the states are facing multibillion-dollar deficits now ...
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...
Joan B Soriano had no particular aspiration to become a doctor, and no one in his family studied Medicine. But growing up in ...
Asthma is one of the most common chronic respiratory conditions, with around 300 million people living with the condition ...
The primary efficacy outcome among the 550 participants with initially uncontrolled asthma showed significantly better ...
A new scientific discovery is offering a promising breakthrough for people struggling with hay fever and asthma triggered by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results